SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-007933
Filing Date
2019-03-15
Accepted
2019-03-15 08:04:08
Documents
2
Effectiveness Date
2019-03-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A vtvt-defa14a_20190315.htm DEFA14A 46670
2 GRAPHIC g5v2yajq40lc000001.jpg GRAPHIC 90769
  Complete submission text file 0001564590-19-007933.txt   172906
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37524 | Film No.: 19683005
SIC: 2834 Pharmaceutical Preparations